ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
Active, not recruiting · NCT05355298 · Registry updated 2026-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT05355298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amplia Therapeutics Limited | 2 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Calvary Mater Newcastle | Waratah | Australia | 49 |
| Epworth Healthcare | Richmond | Australia | 13 |
| Epworth Healthcare | Box Hill | Australia | 1 |
| Gallipolli Medical Research Foundation | Greenslopes | Australia | 1 |
| GenesisCare | St Leonards | Australia | 2 |
| Monash Health | Clayton | Australia | 74 |
| National Cancer Centre | Gyeonggi-do | South Korea | 2 |
| Samsung Medical Centre | Seoul | South Korea | 1 |
| Seoul National University Bundang Hospital | Gyeonggi-do | South Korea | 21 |
| Seoul National University Hospital | Seoul | South Korea | 40 |
| Severence Hospital | Seoul | South Korea | 1 |
| Western Health | St Albans | Australia | 3 |
| Westmead Hospital | Westmead | Australia | 128 |